Peptidergic
neurons and neurosecretory ceils often contain multiple peptides, where they may be present in characteristic ratios. In this article, we describe how a set of five colocalized and coreleased peptides, two adipokinetic hormones (AKH I and AKH II), and three dimeric peptides (APRP 1, 2, and 3) are synthesized by the neurosecretory cells of the corpora cardiaca of the locust Schistocerca gregaria. We show that the five peptides are produced from two prohormones called pro-AKH I, or A-chain, and pro-AKH II, or B-chain. The amino acid sequences as determined by direct protein sequencing are given for both. Prior to processing, the two prohormones form the three possible dimers by the oxidation of the single cysteine residues found in each. The dimers, not the prohormones, are the direct precursors of the peptides.
The dimeric precursors are called Pl (A-A), P2 (A-B), and P3 (B-B). Processing
results in the generation of the two AKH peptides and the three dimers called adipokinetic hormone precursor-related peptides, or APRPs. Throughout postembryonic development, we show that the ratios of the AKHs and APRPs change dramatically and systematically.
We show that these changes can be explained by the differential regulation of the synthesis of the two prohormones and their random association into dimers that are then completely processed. Regulation of peptide stoichiometry may expand the potential information content of the signals generated by multipeptide-producing neurons.
Many peptide-producing neurons and neurosecretory cells generate multiple chemical signals by coproducing more than one peptide. The possibility arises, therefore, that an element of the chemical signal from such cells may be embodied in the ratios of the peptides produced. If peptide ratios represent signaling information, we may expect a strict regulation of peptide stoichiometry in multiple peptide-producing cells. An example of stoichiometry regulation has been found in the egg-laying hormone (ELH)-producing bag cells ofAplysia (Fisher et al., 1988) . In these cells, ELH is represented once in a prohormone that also contains several other potential peptide signals. The stoichiometry of the peptides in the bag cells is, however, not the same as the stoichiometry of those peptides within the ELH precursor protein. The stoichiometry of the bag cell peptides appears to be regulated by a process requiring the differential degradation ofa set ofvesicles containing the non-ELH peptides.
In this way, the ratios of released peptides are not predicted by the fixed stoichiometry of the peptides in the ELH precursor.
Here we describe a system of neurosecretory cells in which peptide stoichiometry changes systematically throughout postembryonic development. In spite of these changes, however, the peptide ratios are predicted by the fixed ratios of those peptides in their precursors. Differential regulation of peptide amounts is possible in this system because the peptides are contained in the structures of two colocalized prohormones whose synthesis is independently regulated. Additional flexibility of peptide stoichiometry is provided by the fact that the prohormones surprisingly are not the direct precursors of the peptides. Prior to processing, the prohormones are dimerized into two homo-and one heterodimer, and these three dimeric structures are the direct precursors. This allows the ratios of the monomer peptides (adipokinetic hormones, AKHs) to be altered at a different rate than the ratios of the dimer peptides (AKH precursorrelated peptides, APRPs) derived from the precursors. Here we provide, for the first time, the complete structures of the three dimeric precursors and the structures of all of their products of processing. These include the three dimer peptides called the APRP 1, -2, and -3. Our developmental studies show how the relative amounts of these peptides change throughout postembryonic development and how these changes can be explained by differential regulation of prohormone biosynthesis.
The neurosecretory cells of the corpora cardiaca (CC), major neuroendocrine organs of the desert locust Schistocerca gregaria, produce, store, and release two neuropeptides with extensive sequence homology-the adipokinetic hormones (AKH I and AKH II) (Goldsworthy et al., 1972a,b; see Orchard, 1987, for review) . Both are released into the circulation upon the initiation of flight behavior (Mayer and Candy, 1969) and they function to mobilize diacylglycerols from fat cells. In this way, they allow the animal to use lipid as an energy source during flight, thus permitting locusts to migrate great distances without feeding. AKH I is a IO-amino acid peptide, pGlu-Leu-Asn-Phe-ThrPro-Asn-Trp-Gly-Thr-NH2 (Stone et al., 1976) and AKH II is 8 amino acids, pGlu-Leu-Asn-Phe-Ser-Thr-Gly-Trp-NH: (Siegert et al., 1985) . The CC consist of two distinct lobes, the storage and glandular lobes. The storage lobes are made primarily from the nerve endings of neurosecretory cells contained in the brain, to which they are connected by two paired nerves, and do not contain AKHs. By contrast, the glandular lobes contain an apparently uniform population of intrinsic neurosecretory cells (Rademakers and Beenakkers, 1977; Schooneveld et al., 1983; Hekimi and O'Shea, 1987 ) that produce both AKH I and AKH II in large amounts. Thus, the glandular lobes of the CC represent an AKH "peptide factory" much like the insulin-producing P-cells or the ELH-producing bag cells of Aplysia (see Sossin et al., 1989, for review) . This feature of the glandular CC, coupled to the fact that they can be maintained easily in vitro, has made direct biochemical studies on the biosynthesis of the AKH neuropeptides and their precursors possible. In a series of in vitro pulse-labeling experiments, two precursors of the AKHs called Pl and P2, both of about 8.4 kDa, were identified O'Shea, 1987,1989a) .
These experiments indicated that Pl is precursor to AKH I, the more abundant of the two hormones, and P2 is precursor to both AKH I and AKH II. When processed, Pl and P2 not only generate the AKHs but also two additional peptides that were named APRP 1 and APRP 2. The APRPs and the AKHs are released from the CC in a calcium-dependent manner when the neurosecretory cells are depolarized (Hekimi and O'Shea, 1989) . The size of the APRPs (about 6.5 kDa each) showed that they are major fragments of their precursors; indeed, it was clear from size considerations alone that Pl and P2 could accommodate only one copy of a 6.5 kDa APRP and at most two AKH sequences each. Taken together, the evidence indicated that Pl consisted of two copies of AKH I (1 kDa each) and one copy of the 6.5 kDa APRP 1, and P2 consisted of one AKH I, one AKH II (0.8 kDa), and one copy of APRP 2. For Pl, these structural predictions were subsequently confirmed by amino acid sequencing (Hekimi et al., 1989) . The amino acid sequences and structures of P2, APRP 2, a third precursor (P3), and a third APRP have now been determined and are included in the Results. The structure of Pl was determined following protein sequencing performed directly on the isolated and purified precursor (Hekimi et al., 1989) . While the general structural features indicated from sizing experiments (two AKH I molecules and one APRP 1 per Pl) were confirmed by sequencing, one structural feature of the precursor Pl was entirely unexpected. The precursor P 1 is a dimer formed from two identical 4 1 -residue subunits. Each subunit consists of one AKH I sequence (10 amino acids starting with pyroglutamic acid) followed by a canonical Gly-Lys-Arg processing site and then a 28-residue carboxy-terminal peptide named the a-chain containing a single cysteine. APRP 1 was shown to be a dimer of the 28-residue a-chain. We call the subunit of the Pl precursor the A-chain. It is produced by a small mRNA (500 nucleotides) that encodes a very small 63-amino acid protein (prepro-AKH I) consisting of a 22-residue hydrophobic leader peptide followed by just one copy of the A-chain terminated by a stop codon (Schulz-Aellen et al., 1989) . The A-chain is therefore by convention pro-AKH I, and we use the two terms interchangeably.
This and additional evidence from in vitro translation experiments show that the homodimer Pl is made from independently translated A-chain monomers rather than from a larger prohormone containing more than one copy of the A-chain. Note that the AKH I prohormone (A-chain) is not the direct antecedent of AKH I because processing occurs in its dimeric form, Pl . In this article, therefore, we draw a distinction between prohormone (the product of translation less the leader sequence) and precursor (the form of the prohormone that is processed).
This structural work on Pl provided the key to understanding the biosynthetic pathway for the complete complement of five peptides produced in the CC. In this article, as a prelude to developmental studies also reported here, we describe the formation, structure, and processing ofthe three dimeric precursors of the AKHs and APRPs. We show that like Pl, P2 is a dimer consisting of one A-chain (pro-AKH I) and a different but homologous polypeptide we call the B-chain. The B-chain is pro-AKH II and consists of AKH II, a processing site followed by a 28-residue carboxy-terminal sequence called the P-chain. This unusual molecular organization of dimeric precursors suggested the possible existence of an as yet unidentified third precursor (B-chain homodimer) and a third APRP (p-chain homodimer). Here we demonstrate that the complete set of the three possible dimer precursors is synthesized in the CC. Using subunit-specific antisera, we also show that the A-chain and B-chain are found in the same cells and that all cells in the CC contain both. The two subunits are thus available to one another in all cells for dimer formation.
Developmental studies show that systematic changes in the ratios of the AKH and APRP peptides occur throughout postembryonic development. These changes can be predicted if we assume that independently translated A-and B-chains (or pro-AKH I and pro-AKH II) associate randomly with one another producing ratios of dimeric precursors according to binomial distributions. Kinetic considerations localize the formation of dimer precursors to the endoplasmic reticulum.
The random association model suggests that the changing peptide stoichiometries at different stages of development are produced by the differential regulation of the synthesis of the independently translated subunits alone.
Materials and Methods
Animals. Adult locusts (Schistocerca gregaria) used in this study were reared in our laboratory culture. CC dissected from more than 8000 individual locusts were used in this study. Female New Zealand White rabbits produced the antisera used for the immunocytochemical analysis. Organ culture. Details of in vitro incubation methods were given in O'Shea (1987, 1989a) and Hekimi et al. (1989) . Briefly, CC were removed from individual animals and incubated in the presence of radiolabeled ('H or "C) amino acids in 100 ~1 of physiological saline (see Results and figure captions for labeling protocols used in the various experiments). Up to 50 CC can be incubated in this volume. Following varying durations of incubation with the labeled amino acid, the CC were either washed in saline and subjected to chromatography or transferred to a large volume of translation block medium in order to chase label from precursor to product. The translation block medium contained saline including 1 pg per cycloheximide.
Extraction, identification, and purification procedures. Corpora cardiaca were homogenized in 100 ~1 of 0.1% trifluoroacetic acid (TFA) at room temperature with an ultrasound cell disrupter. The TFA-soluble supematant was removed and subjected to size-exclusion or reversephase chromatography. On-line detection was provided by a fixed wavelength absorbent detector set at 2 14 nm. In some experiments, HPLC fractions were also subjected to scintillation counting. For size fractionation, a 60 cm TSK 2000 gel permeation column eluted at 0.5 ml/ min with 0.1% TFA containing 15% (vol/vol) acetonitrile was used. Complete details of procedures for calibrating the size-exclusion column have been provided previously (Hekimi and O'Shea, 1989a) . Reversephase chromatography was achieved using a C8 wide-pore column (300 A) eluted at 1.5 ml/min with a linear gradient from 25% to 45% acetonitrile in 0.1% TFA at l%/min. Criteria for the identification of peaks using synthetic peptides have been established previously (Hekimi and O'Shea, 1989) .
Cleavage of the disultide bonds between the subunits of the APRPs and Ps was obtained by reduction of peptides in 0.1 M Tris-HCl, pH 8, with a IO-fold excess of @-mercaptoethanol. Prior to sizing on the TSK The peptides were eluted using a linear gradient of acetonitrile in 0.1% TFA (2545%). Notice that, especially in the adult chromatogram, the pattern of OD peaks of this crude aqueous extract is extremely simple. The positions and optical densities of the peptides and precursors (except P3) referred to in this article are indicated. The more complex pattern ofadditional peaks found in B is largely due to contamination from non-glandular lobe tissue that inevitably enters the extract because of the increased difficulty of dissecting pure glandular lobes from the relatively smaller CC from the earlier developmental stages. The differences in the stoichiometries of the peptides are auuarent in comnarina A and B. especialiy for the APiP 1 and APRP 2 peaks. \'-!u 2000 column, the products of reduction were purified by reverse-phase chromatography. Amino acidsequencingand analysis. Automated Edman degradations were performed with an Applied Biosystems 470A gas phase sequencer. The amino acids were identified using the on-line Applied Biosystems 120A phenylthiohydantoin analyzer. Amino acid composition of the P-chain subunit of APRP 2 was determined using the protocol of Bidlingmeyer et al. (1984) . Gas phase hydrolysis with 6N HCI was carried out for 24 hr at 108°C. The phenylthiocarbamyl amino acid derivatives were analyzed by reverse-phase HPLC on a Hewlett Packard 1090 liquid chromatograph using a Vidac Cl8 column. More complete technical details relating to amino acid sequencing and analysis can be found in Hekimi et al. (1989) .
Antibodies and immunocytochemistry. Oligopeptides (Lys-Tyr [AKHI,S-IO] and Lys-Tyr [AKHII,Z-81) were conjugated to the protein carrier KLH through the N-terminal lysyl residue using glutaraldehyde. The crude conjugate was then dialyzed to remove unconjugated peptides, and rabbits were injected subcutaneously with 1.5 mg ofconjugate in 0.75 ml PBS, pH 7, mixed with 0.75 ml of Freund's complete adjuvant. The specificity for the AKH I and AKH II antisera using radioimmunoassay has been previously described (Hekimi and O'Shea, 1989b) .
For immunocytochemistry, CC were fixed in situ with a modified Bouin's fixative (75% aqueous saturated picric acid with 4% formaldehyde) and embedded in parablast. Seven-micrometer sections were mounted on ovalbumin-coated slides. Antigen localization was detected using the peroxidase-antiperoxidase (PAP) technique. Sections were rehydrated, preincubated in 3% normal goat serum (NGS) in PB buffer (0.1 M NaPO,, pH 7.4), and incubated 20 hr in the dark at 4°C with the antisera diluted 1: 1000 to 1:2500 in PB with 1% NGS. Sections were washed with PB, incubated 30 min with a goat anti-rabbit serum (Nordic, 1:20 in PB with 1% NGS), rinsed, and incubated 30 min with PAP (Nordic, I:40 in PB with 1% NGS). After washes, the immuno- reactive material was revealed using 3,3'-diaminobenzidine (DAB; Fluka; 25 mg DAB/I00 ml PB + 0.01% H,O,). To demonstrate staining specificities, blocking experiments were performed by preincubating the antisera 1 hr at room temperature in the dark with 5-10 FM AKH Iand AKH II-related antigens.
Results
The peptide content of the glandular cells of the CC A crude aqueous extract of the neurosecretory cells of the CC shows a very simple pattern of optical density peaks when subjected to reverse-phase chromatography. The simplicity of this pattern of peaks reflects the homogeneity of the tissue with respect to neuropeptide synthesis. Figure 1 shows this pattern in a typical profile in which the positions of peptides referred to in this article are indicated. Notice that there are only four prominent optical density peaks, AKH I and AKH II and APRP 1 and APRP 2. The much smaller peaks attributed to the Pl and P2 precursors migrate just ahead of the major APRP peaks. That Pl and P2 are precursors to the AKHs and APRP 1 and APRP 2 has been established by performing pulse-chase experiments on glands maintained in short-term tissue culture and provided with radiolabeled amino acids O'Shea, 1987, 1989a) . Structural analysis by protein sequencing of Pl has confirmed its identity as precursor to two AKH I molecules and one APRP 1 (Hekimi et al., 1989) . Previously reported pulse-chase experiments indicated that P2 was precursor to AKH I and AKH II and the 6.5 kDa APRP 2. The complete primary structures of P2 and APRP 2 are determined in the present study, as are the identities and structures of a third precursor (P3) and a product (APRP 3).
The second chromatographic profile shown in Figure 1B is from the CC of a pre-adult larval stage (fourth instar). While the same peptides are identifiable in the larval CC, they occur in quite different relative amounts than in adults. For example, in the adult there is approximately a 2.5:l ratio of APRP 1 to APRP 2, whereas in the fourth instar this ratio approaches 1: 1. Similarly, the AKH I to AKH II ratios are also different in the adult (-5: 1) and the fourth instar (-3: 1). An explanation for these changing product stoichiometries is given below.
Structure of APRP 2
Our previous studies on APRP 1 suggested that APRP 2 may also be a dimer, so it was analyzed in both its reduced and native forms. Using size-exclusion HPLC, native APRP 2 is about 6.4 kDa but when reduced produces a single peak of 3.2 kDa. Both values are very similar to the size estimates achieved previously for native and reduced APRP 1. When subjected to reversephase chromatography, reduced APRP 2 produces two optical density peaks of similar amplitude, whereas APRP 1, because it is a homodimer, produces a single peak. One of the subunits from reduced APRP 2 coelutes with the a-chain subunit of APRP 1, the other having a longer retention time (Fig. 2) . We call the second subunit of APRP 2 the p-chain. Size-exclusion chromatography does not allow us to distinguish between the cy-and P-chains, indicating that they are of similar size (-3.2 kDa). That they can be separated by reverse-phase chromatography shows that the LY-and P-chain subunits of APRP 2 are different peptides.
For sequence analysis, APRP 2 was reduced and alkylated, and the two subunits were subjected to amino acid sequencing following HPLC purification. The earlier-eluting peak gave, as expected, the complete sequence of the a-chain only. The p-chain subunit produced a different, but related, 28-residue sequence. Both sequences are given in Figure 3 , in which the structure of APRP 2 as a disulfide-bridged heterodimer is given. In order to ensure that Edman sequencing was complete, both peptides present in reduced APRP 2 were subjected to hydrolysis followed by amino acid analysis. The amino acid compositions of the two peaks in APRP 2 (Table 1) indicated that the sequence analysis accounted for all the residues.
Structure of P2 Structural analysis of P2, presumptive precursor of AKH I, AKH II, and APRP 2, was more problematic primarily because it is present in very small amounts, less than half the level of Pl. The low abundance of P2 meant that we could not easily monitor its optical density in the various experiments used to purify it and determine its size and structure. For monitoring, therefore, we used biosynthetically radiolabeled P2 produced by providing CC with 3H-Trp or 14C-Trp during in vitro biosynthesis.
Native P2 is about 8.4 kDa (Hekimi and O'Shea, 1989a) . When reduced and subjected to size-exclusion chromatography, biosynthetically labeled P2 shows a reduction in size to about half the native value, producing a single peak of label in gel filtration chromatography (data not shown). Using reverse-phase chromatography, however, reduced [I%-Trp]-P2 is resolved into two labeled peaks, one ofwhich comigrates with the labeled A-chain derived from reduced [jH-Trp]-Pl (Fig. 4) . These results are This peak has been shown previously by sequencing to be the 28-residue a-chain. In the middle panel, reduced APRP 2 produces two peaks, one comigrating with the a-chain of APRP 1. The two peaks generated from reduced APRP 2 have approximately equal areas, indicating subunits present in equimolar amounts. The later-eluting peak is shown in this article to be the 28-residue peptide called the ,&chain. In the lower panel, reduced APRP 1 and reduced APRP 2 are mixed in equal amounts prior to reverse-phase separation. A peak comigrating with the a-chain, which is approximately three times the integrated area ofthe peak comigrating with the &chain, is produced. This would be expected from the proposed homodimeric structure of APRP 1 and heterodimeric structure of APRP 2. consistent with P2 being a heterodimer formed by an A-chain and another subunit of similar size, presumably containing AKH II and the P-chain of APRP 2. To provide direct evidence for this, we undertook to sequence the second subunit of P2 by automated Edman degradation. Attempts to purify P2 in sufficient quantity for sequencing proved impractical because separating it from APRP 2, with which it virtually comigrates, involved several steps of reversephase HPLC. Our efforts in this direction consumed approximately 5000 individually dissected CC and finally did yield a few picomoles of pure protein. Unfortunately, this amount, following further losses incurred during digestion with pyroglutamate aminopeptidase, was insufficient for sequencing. We therefore decided to sequence P2 (extracted from 3000 CC) following only one step of reverse-phase HPLC purification. Such a sample of P2 would generate a mixture of sequences because not only would it include APRP 2, but P2 itself consists of two subunits. Following digestion with pyroglutamate aminopeptidase to remove amino-terminal pyroglutamate residues, the P2 preparation did reveal a mixture of sequences. The sequence for the A-chain subunit of Pl and the two subunits of APRP 2 were obtained as expected, as well as the as yet undetermined sequence of the second subunit contained in P2.
This sequence begins with the second residue of AKH II and continues through AKH II and a processing site into the sequence for the p-chain. From the inability to obtain sequence before digestion with pyroglutamate aminopeptidase and from the known sequence of AKH II that starts with pyroglutamic acid, we deduce that pyroglutamaic acid is at the amino terminus of the sequence. Sequencing of the second subunit of P2 continued through the first 13 residues of the P-chain before the signal became impossible to read. A protein sequencing ambiguity at the processing site was resolved by cDNA cloning (M.-F. Schulz-Aellen, personal communication) and Arg-Arg is assigned for the B-chain, whereas for the A-chain the basic residues at this position are Lys-Arg. This sequencing data, together with the sizing evidence cited above and the known heterodimeric structure of APRP 2, indicated that P2 is a disulfide-bridged heterodimer formed from two prohormones, pro-AKH I or A-chain and pro-AKH II or B-chain (Fig. 3) . Processing of the P2 heterodimer therefore yields AKH I and AKH II in equimolar amounts and one copy of APRP 2. Note that both the A-and B-chains have a single dibasic processing site preceded by glycine. Glycine, as in other examples, provides the amidated C-terminal residue for AKH I and AKH II (Eipper et al., 1983 (Eipper et al., , 1987 . Interestingly, the dibasic site following glycine is different in two subunits, Lys-Arg for the A-chain and Arg-Arg for the B-chain. Also, a second but unused potential dibasic processing site exists (Arg-Lys) in both the 28-residue C-terminal (Y-and P-chains. The sequence for pro-AKH II or the B-chain of P2 as determined by protein sequencing has been fully confirmed by two independent cDNA cloning experiments in which the amino acid sequence was assigned by inference from a cloned cDNA (Noyes and Schaffer, 1990 ; Schulz-Aellen, personal communication). Although in many other systems cDNA cloning has provided a way to deduce prohormone structures, in this particular system it could not have predicted the actual dimeric nature of the direct precursors of the AKHs. The unusual properties of the CC have allowed us to perform direct structured experiments on the AKH precursors, and only in this way were their true dimeric structures assigned.
Ident$cation of a third dimeric AKH precursor (P3) and its cleavage product APRP 3 The existence of a heterodimeric structure of P2 shows that pro-AKH I and pro-AKH II must, at least in some CC neurosecretory cells, exist in the same subcellular compartment. There is therefore no a priori reason why pro-AKH II or B-chains should not associate with one another to form a third precursor-a homodimer ofpro-AKH II, P3-which would be processed into two copies of AKH II and a P-chain homodimer, APRP 3. With this in mind, we searched for previously unidentified components of the AKH biosynthetic pathway, P3 and APRP 3. That P3 and APRP 3 were not detected in our earlier studies suggested that they are relatively minor components of the system. We can now confirm that they do exist and that in the adult CC they are indeed minor components. Confirmation of their albeit meager existence, however, completes the posttranslational molecular model for AKH I and AKH II biosynthesis and has allowed us to understand the changing peptide stoichiometries in the CC.
To identify P3, we used the pulse-labeling paradigm described previously for the identification and characterization of Pl and P2. We incubated CC in the presence of )H-Trp and searched for proteins from which label can be chased into the tryptophancontaining AKHs. The chromatogram revealed a third but minor labeled peak from which the 3H-Trp disappeared during a chase experiment. This peak was purified and identified as the predicted third dimeric precursor (P3) by the following observations. In complete agreement with the expected behavior of the pro-AKH II homodimer, when reduced it produced a single labeled peak exactly comigrating with the B-chain derived from the reduction of P2. The existence of P3 is further supported by direct evidence for the production of a p-chain homodimer (APRP 3) in the CC. An optical density peak that is retained on the reverse-phase column even longer than APRP 2 (see Fig.  1 ) has been positively identified by protein sequencing as the third APRP with the expected P-chain homodimer structure. When reduced, APRP 3 produced a single peak ofoptical density comigrating in reverse-phase HPLC with the P-chain derived from APRP 2. Sufficient quantity of this peak was purified for protein sequencing, and this revealed only the complete primary structure of the p-chain. We propose that it is derived from P3, which when processed yields two AKH II molecules and one APRP 3.
Together, our experiments suggest a model for AKH biosynthesis in the CC according to which AKH I, AKH II, and three APRPs are generated by processing a complete set of three dimerit precursors produced from two prohormone subunits (Fig.  5) . This biosynthetic scheme can provide an explanation for the relative abundance of each of the component proteins and peptides involved in neuropeptide biosynthesis in the CC (see below).
Cellular colocalization is the rule The existence in the CC of the heterodimeric precursor P2 shows, as mentioned above, that at least some of the neurosecretory cells of the CC must synthesize both subunits. Such cells therefore may each contain all three dimeric precursors (Pl, P2, and P3) in addition to all possible products (AKH I, AKH II, and the three APRPs). In order to link our molecular biological studies of AKH biosynthesis to the cell biology of the CC, we needed to know if all AKH-expressing cells in the CC contain both subunits of the dimeric precursors. Antibodies with spec- ificities designed to distinguish between pro-AIM I and pro-AKH II were therefore produced. These antibodies were raised against two synthetic oligopeptides that were designed to exploit the difference between AKH I and AKH II. The AKH I-specific antiserum was raised against Lys-Tyr[AKH I, 5-101, and the AKH II-specific serum was raised against Lys-Tyr[AKH II, 2-8]. The production and characterization of these antibodies that discriminate between AKH I and AKH II in a radioimmunoassay has been described previously (Hekimi and O'Shea, 1989b) . For application in this study, we needed to demonstrate specificity of the immunoreactivity in immunocytochemistry by demonstrating differential blockade of staining following preabsorption with the oligopeptide antigens. Using these antisera in immunocytochemical experiments on the CC, we have investigated whether all neurosecretory cells make both pro-AKH I and pro-AKH II or whether some cells exist that synthesize only one or the other. Figure 6 shows that all immunoreactive cells in the CC are immunopositive for both AKH I and AKH II. It appears, therefore, that all neurosecretory cells in the glandular lobes of the CC are able to synthesize both subunits of the three precursors. Since all cells appear to be equivalent, our molecular scheme derived from experiments performed on whole glands can represent events occurring in individual CC cells. Results of wholegland biochemical experiments might therefore legitimately be interpreted in terms of cellular and molecular events occurring in individual cells.
Random and rapid dimerization of prohormones.followed by complete processing explains the characteristic stoichiometry of precursors and products Pro-AKH I and pro-AKH II do not accumulate sufficiently to be reliably detected in our in vitro pulse-labeling experiments. When synthesis proceeds in vitro in the presence of 'H-Trp, radiolabel can first be detected in dimerized precursors within a few minutes. It accumulates in the dimer precursors for 5-6 hr before reaching a steady-state level. The virtual absence of the monomer prohormones and the rapid appearance and accumulation of label in the dimer precursors indicate that dimerization occurs very close to the site of prohormone translocation into the endoplasmic reticulum. Indeed, dimerization may occur virtually cotranslocationally. In contrast to this very rapid posttranslational event, processing of the dimeric precursors to their products is delayed, as indicated by the delayed appearance of labeled AKH and by the accumulation of label in unprocessed precursors. During continuous incubation with 3H-Trp, label in the AKHs begins to accumulate linearly when a steady-state level of label in the precursors is reached (Hekimi and O'Shea, 1987) . These observations indicate that AKH biosynthesis involves the dimerization of prohormones in the endoplasmic reticulum followed by delayed transport and processing in another subcellular compartment (Fig. 5) .
In the adult CC, there is a striking and characteristic imbalance in the relative amounts and rates of synthesis of dimeric precursors and their monomeric and dimeric products. The largest imbalance is between the absolute level of precursors and products. A single CC from mature adult can contain as much as 1 nmol of AKH I. The dimeric precursors, however, because they are metabolic intermediates, are present in far lower levels (picomolar and subpicomolar levels per CC) and are difficult or, in the case of P3, impossible to measure by their optical density. More interesting than the relatively low abundance of precursors compared to products are the changing relative levels of the various components of the biosynthetic pathway. For example, in the adult, the synthesis of Pl proceeds at about twice the rate of P2, and P3 synthesis is virtually nil by comparison. Related to these differences in precursor synthesis rates, the product ratios also show characteristic imbalances. The adult AKH I to AKH II ratio is almost 5: 1, and the APRP 1 to APRP 2 ratio is more than 2: 1, with relatively little APRP 3. Some of these differences in product ratios are apparent in Figure 1 .
These differing ratios can be explained by our molecular model (Fig. 5) if we make some simple assumptions. Consider, for example, a situation where the precursor subunits, pro-AKH I and pro-AKH II, are available for dimer formation in equal amounts. Assuming random dimerization with no preferential association, there would be a perfect binomial distribution (1: 2: 1) of the dimeric precursors Pl:P2:P3. Ifwe also assume complete processing of precursors, this would lead to an AKH I to AKH II ratio of 1: 1 and a binomial distribution of the APRPs of 1:2: 1. Any differences in the relative availability of the sub- units would be reflected in skewed binomial distributions of precursors and products. These ideas could be tested experimentally ifwe were able to estimate the relative rates of synthesis of the two prohormones. We are unable, however, to measure directly the relative rates of synthesis of the A-and B-chains because, as indicated above, dimerization is very rapid and the first sign of AKH biosynthesis is label appearing in the accumulating dimeric precursors. Since, however, the A-chain contains one copy of AKH I and the B-chain contains one copy of AKH II, a reflection of their relative rates of synthesis can be obtained from measuring the relative amounts of AKH I and AKH II produced. In the adult CC, the relative proportion of AKH I to AKH II approaches 5: 1, suggesting that there may be almost five times as much A-chain as B-chain translated. Assuming a 5: 1 ratio of A-chain to B-chain and assuming random association, there would be a skewed binomial distribution of Pl:P2:P3 producing ratios of 25: 10: 1. Furthermore, if the precursors in these ratios are all completely processed, a 5: 1 ratio of AKH I to AU-I II would be accompanied by a 2.5: 1 ratio between APRP 1 and APRP 2 (with APRP 3 being '/,,th of APRP 1). Ratios very close to these relationships are found in the adult CC, so our assumptions concerning the free random association of A-and B-chains and their complete processing may be valid. We suggest, therefore, that the ratios of the AKHs and APRPs are determined by the relative synthesis rates of the two prohormones alone. An opportunity to test this hypothesis is provided by studies on the CC at different stages of postembryonic development during which product stoichiometries change systematically.
Developmental regulation of synthesis
During postembryonic development, lasting about 5 weeks, the locust passes through five larval stages or instars before moulting to the winged adult. Throughout this period, the CC grow and absolute amounts of the AKHs and APRPs increase dramatically. For example, adult levels of AKH I are approximately 500-fold greater than in the first larval stage or first instar. Increase of absolute amounts of peptide is relatively greater than the rate of growth of the organism as a whole, and this results in increased peptide levels when amounts are normalized to body weight. While levels of all CC peptides increase during development, they do not increase at equal rates. For example, the increase in AKH I during postembryonic development is greater than the increase in AKH II, and this produces systematic changes in the relative amounts or ratios of the peptides (Fig. 7) . Notice that in the first larval stage the AKH I to AKH II ratio is close to 1: 1, whereas in the adult the ratio approaches 5: 1, and also that the normalized levels of both AKH I and AKH II increase abruptly in late postembryonic development and in the adult. This latter feature is interesting because the AKHs are involved in regulating lipid metabolism during flight and flight is an entirely adult behavior. During the last two postembryonic transitions (from fourth to fifth and from fifth to adult), there is a partial metamorphosis involving the rapid development of wings. Metamorphosis is known in insects to be associated with a fall in the titer ofjuvenile hormone, so this hormonal change may also trigger the upregulation of AM biosynthesis.
At the same time that the AKH ratios change, the APRP ratios also change systematically. Indeed, the changes in the APRP ratios are even more pronounced. For example, in the first larval stage the APRP 1 to APRP 2 ratio is approximately 0.5: 1, and in the adult, approximately 2: 1. A comparison between the postembryonic developmental changes in the relative amounts of the AKHs and APRP 1 and APRP 2 is shown in Figure 8 . Notice that the developmental change in the AKH ratio is less than the change in the APRP ratio by a factor of approximately 2. Thus, for the whole period of postembryonic development, the AKH ratio changes by about 2.7-fold, whereas the APRP ratio changes by approximately 4.7-fold.
How can these complex changes in peptide relative levels and ratios be simply explained? Our data suggest strongly that the explanation is to be found in the changing relative rates of synthesis of the two prohormones, the A-and B-chains. This being so, we ought to be able to show a predictable correlation between relative rates of precursor synthesis and the relative Specificity is indicated in B and C by the demonstration of a blockade of staining when the antibody is preincubated with AKH I, but not with AKH II. In the lower panels, a similar series of sections demonstrates the presence of AKH II in the neurosecretory cells of the CC. In these panels, staining blockade occurs when the antibody is preabsorbed with AKH II (F), but not with AKH I (E). Scale bar, 100 pm. amounts of processed peptides at different stages of development. Precursor synthesis can be measured at different stages of postembryonic development by comparing the incorporation of the 'H-Trp into Pl and P2 (the two most easily monitored precursors) during precursor synthesis in vitro. As each prohormone contains the same number of tryptophan residues, the amount oftritium coeluting with Pl and P2 indicates the relative synthesis rates of the precursors. As expected from the measurements of AKH synthesis throughout development, there are changes in the relative rates of Pl and P2 synthesis as a function of stage of postembryonic development. For example, in the first instar CC the Pl to P2 ratio is approximately 0.5: 1, whereas in the adult it is more than 2: 1. These results suggest that the changes in the pattern of neuropeptide stoichiometry are being driven by developmentally regulated changes in the rates of precursor biosynthesis. Our molecular model for the biosynthesis of AKH I and AKH II (Fig. 5) can be used to make specific predictions about the expected relative amounts of AKH I and AKH II and the APRPs when the rates of synthesis of the precursors are altered. Assuming that the two subunits of the precursors associate randomly into the dimers that are then completely processed, we can calculate the expected AKH I to AKH II and APRP 1 to APRP 2 ratios from the Pl :P2 synthesis ratio alone. For example, since Pl and P2 each contain one copy of an APRP, the slope of the relationship between the Pl to P2 ratio and the APRP 1 to APRP 2 ratio should be 1. Since, however, there is twice as much AISH I in Pl as in P2, the relationship between a changing precursor ratio (P 1 :P2) and the AKH I to AKH II ratio should have a slope of '12. Notice that from this we would expect the APRP 1 to APRP 2 ratio to change at twice the rate of the AKH ratio during development. A twofold change in the AKH ratio would therefore be associated with a fourfold change in the APRP ratios. This expected association is close to the experimentally measured difference between changing AKH and APRP ratios, as illustrated in Figure 8 . Body Weight (mg) Figure   7 . Postembryonic developmental changes in the amounts of AKH I and AKH II per CC normalized to body weight. Levels of both peptides increase throughout postembryonic development, but the increase in AKH II is greater than the increase in AKH I, producing progressive shifts in the ratios between the two peptides. The developmental changes in these ratios are plotted in Figure 8 , in comparison to developmental changes in APRP ratios. The numbers beside the data points (Zs'-Yh) indicate the postembryonic larval stages and development. The error bars indicate +-1 SD.
Discussion
A test of the biosynthetic model As a test of our hypothesis and to determine whether changing peptide stoichiometries were driven by changing relative rates of precursor biosynthesis, we examined the relationship throughout postembryonic development between the experimentally determined rates of Pl and P2 synthesis and the experimentally determined amounts of the peptides present. Figure 9 shows that these experimentally derived data points fall close to the two slopes theoretically derived from binomial calculations based on the assumption of random association of two prohormones. The close correspondence between observed and predicted ratios suggests that our molecular model and the assumptions related to it are largely valid. In conclusion, the changes in neuropeptide ratios seen in postembryonic development can most simply be explained by the differential regulation of the synthesis of the two prohormones, the A-and B-chain subunits of the dimeric precursors. We do not know precisely how regulation of the subunit of biosynthesis is achieved, but in general terms this may be either largely transcriptional or translational. Whatever the mechanism, however, it is clear that the CC show strong differential control on neuropeptide precursor biosynthesis and this results in complex but systematic and expected changes in neuropeptide stoichiometry.
Sign$cance of dimeric precursors and the changing peptide ratios Perhaps there is signaling information contained in peptide ratios. It is appealing to think that information could be encoded in neuropeptide ratios because unlike the absolute levels of peptides, which might be more difficult to regulate, ratios can be regulated simply by changing relative synthesis rates of precur- sors. The ratios therefore could contain signaling information that would be unaffected by nonspecific factors such as nutrition and health, which might alter absolute peptide levels. Although we do not yet know the function of the APRPs, they are coreleased with the AKHs (Hekimi and O'Shea, 1989a) and their amino acid sequences are highly conserved in distantly related locust species (S. Hekimi, J. Fischer-Lougheed, and M. O'Shea, unpublished observations). This suggests they also have signaling or hormonal roles. In spite of our incomplete understanding of the role of the APRPs, it seems unreasonable to assume that there is no biological significance to the changing ratios, especially since these appear to be so precisely, progressively, and systematically varied during development. . Relationship between relative rates of precursor synthesis (Pl to P2) and the relative amounts of products (AKH I to AKH II and APRP 1 to APRP 2) throughout postembryonic development. The slopes of these relationships, as predicted from our molecular model and our assumptions about it, are shown as solid lines. The experimentally derived data points are shown as squares (for the APRP ratios) and circles (for the AKH ratios). There is good agreement between the predicted and observed data, and an explanation for this is provided in the Discussion.
